You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 83 No. 3, March 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Generalized Scleroderma in Children

Acrosclerotic Type

MANUEL O. JAFFE, M.D.; R. K. WINKELMANN, M.D.

Arch Dermatol. 1961;83(3):402-413.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Scleroderma in children is uncommon, and while localized cutaneous forms of the disease occur more frequently among them, cases of generalized scleroderma are especially rare. Two clinical variants of generalized scleroderma have been described: diffuse scleroderma and acrosclerosis.1 Acrosclerosis was first described by Hutchinson,2 and Sellei3 championed its status as a disease sui generis. O'Leary and Waisman4 stressed the importance of vasomotor abnormalities in acrosclerosis and its good prognosis as compared to that of diffuse scleroderma. Acrosclerosis involves predominantly the skin of the face, upper part of the chest, hands, forearms, and occasionally the feet. A vasospastic (Raynaud's) phenomenon is associated with the sclerosis. Varying degrees of systemic involvement may occur, the gastrointestinal, pulmonary, and cardiorenal systems being most frequently affected.

The early dermatologic literature pertaining to scleroderma5-8 in children is confusing because many cases presented as diffuse scleroderma would be, in our opinion, more . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN.

Fellow in Dermatology, Mayo Foundation (Dr. Jaffe); Section of Dermatology (Dr. Winkelmann); Mayo Clinic and Mayo Foundation.


Footnotes

Submitted for publication Sept. 16, 1960.

The Mayo Foundation is a part of the Graduate School of the University of Minnesota.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.